These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1312192)

  • 1. The role of mu1 receptor in physical dependence on morphine using the mu receptor deficient CXBK mouse.
    Suzuki T; Hayashi Y; Misawa M
    Life Sci; 1992; 50(12):849-56. PubMed ID: 1312192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.
    Kamei J; Ohsawa M; Saitoh A; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    J Pharmacol Exp Ther; 1995 Aug; 274(2):700-6. PubMed ID: 7636731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
    Vaught JL; Mathiasen JR; Raffa RB
    J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographic analysis of mu1, mu2, and delta opioid binding in the central nervous system of C57BL/6BY and CXBK (opioid receptor-deficient) mice.
    Moskowitz AS; Goodman RR
    Brain Res; 1985 Dec; 360(1-2):108-16. PubMed ID: 3000528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of morphine withdrawal signs in the rat after chronic treatment with naloxone.
    Suzuki T; Fukagawa Y; Misawa M
    Eur J Pharmacol; 1990 Mar; 178(2):239-42. PubMed ID: 2158457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive effect of buprenorphine in mu1-opioid receptor deficient CXBK mice.
    Kamei J; Sodeyama M; Tsuda M; Suzuki T; Nagase H
    Life Sci; 1997; 60(22):PL 333-7. PubMed ID: 9180346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical dependence on morphine using the mu receptor deficient CXBK mouse.
    Suzuki T; Misawa M
    Prog Clin Biol Res; 1990; 328():519-22. PubMed ID: 2154813
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative involvement of supraspinal and spinal mu opioid receptors in morphine dependence in mice.
    Miyamoto Y; Takemori AE
    Life Sci; 1993; 52(12):1039-44. PubMed ID: 8383266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity to physical dependence on morphine and codeine in three inbred strains of mice.
    Suzuki T; Otani K; Misawa M
    Jpn J Pharmacol; 1991 Dec; 57(4):455-62. PubMed ID: 1803063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors.
    Sánchez-Blázquez P; García-Espãna A; Garzón J
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1423-31. PubMed ID: 9067332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of supraspinal and peripheral naloxonazine-insensitive opioid receptor sites in the expression of μ-opioid receptor agonist-induced physical dependence.
    Mori T; Komiya S; Uzawa N; Inoue K; Itoh T; Aoki S; Shibasaki M; Suzuki T
    Eur J Pharmacol; 2013 Sep; 715(1-3):238-45. PubMed ID: 23707904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence.
    Kest B; Palmese CA; Hopkins E; Adler M; Juni A; Mogil JS
    Neuroscience; 2002; 115(2):463-9. PubMed ID: 12421612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of physical dependence on morphine in mice by the drug-admixed food method.
    Suzuki T; Yoshii T; Yanaura S
    Jpn J Pharmacol; 1984 Mar; 34(3):319-25. PubMed ID: 6539400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the mu 2-opioid receptor in the antitussive effect of morphine in mu 1-opioid receptor-deficient CXBK mice.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1993 Aug; 240(1):99-101. PubMed ID: 8405130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid receptor upregulation in mu-opioid receptor deficient CXBK and outbred Swiss Webster mice.
    Duttaroy A; Shen J; Shah S; Chen B; Sehba F; Carroll J; Yoburn BC
    Life Sci; 1999; 65(2):113-23. PubMed ID: 10416817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precipitation of spinally mediated withdrawal signs by intrathecal administration of naloxone and the mu-receptor antagonist CTP in morphine-dependent mice.
    Shook J; Kazmierski W; Hruby V; Burks T
    NIDA Res Monogr; 1988; 81():143-8. PubMed ID: 2900467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of delta 1 and delta 2 opioid receptor subtypes in the development of physical dependence on morphine in mice.
    Suzuki T; Tsuji M; Mori T; Misawa M; Nagase H
    Pharmacol Biochem Behav; 1997; 57(1-2):293-9. PubMed ID: 9164585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice.
    Dodu JC; Moncayo RK; Damaj MI; Schlosburg JE; Akbarali HI; O'Brien LD; Kendall DA; Wu Z; Lu D; Lichtman AH
    J Pharmacol Exp Ther; 2022 Jan; 380(1):1-14. PubMed ID: 34625464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: comparison of different mouse strains.
    Liu L; Coller JK; Watkins LR; Somogyi AA; Hutchinson MR
    Brain Behav Immun; 2011 Aug; 25(6):1223-32. PubMed ID: 21447380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.